Pfizer’s antiviral oral drug Paxlovid that was developed as an early treatment for Covid-19 can cause severe or life-threatening effects if it is taken in tandem with other common medications including some anticoagulants, anti-depressants, and cholesterol-lowering drugs that are used widely across the US, according to a warning from the Food and Drug Administration (FDA).
There are six pages of warnings with this drug.
In addition to the potentially dangerous drug combinations, the agency does not recommend that individuals with kidney or liver disease take the new drug because it could also cause complications.
Pfizer’s Covid pill regiment – Paxlovid – consists of a mix of two drugs – one being nirmatrelvir, which is meant to stop the SARS-CoV-2 virus from replicating, and the second, ritonavir, is an agent that acts to prolong the duration of the first.
Like Pfizer’s Covid vaccine, the experimental drug has only been granted an Emergency Use Authorization (EUA) by the FDA.
The FDA granted Paxlovid its EUA just one month after Biden’s regime announced that it would be purchasing 10 million courses of the drug.